The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 06, 2019
Filed:
Oct. 31, 2017
Applicant:
Theravance Biopharma R&d Ip, Llc, South San Francisco, CA (US);
Inventors:
Shaoling Li, Sunnyvale, CA (US);
Manshiu Leung, Daly City, CA (US);
Hao Zhang, Foster City, CA (US);
Venkat R. Thalladi, Foster City, CA (US);
Yun Mo, Foster City, CA (US);
Assignee:
THERAVANCE BIOPHARMA R&D IP, LLC, South San Francisco, CA (US);
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/46 (2006.01); A61K 31/439 (2006.01); A61K 31/485 (2006.01); A61K 9/24 (2006.01); A61K 9/28 (2006.01);
U.S. Cl.
CPC ...
A61K 31/46 (2013.01); A61K 9/209 (2013.01); A61K 9/282 (2013.01); A61K 9/284 (2013.01); A61K 9/2853 (2013.01); A61K 9/2893 (2013.01); A61K 31/439 (2013.01); A61K 31/485 (2013.01);
Abstract
The invention provides a solid composition of the peripheral mu opioid antagonist axelopran and a combination dosage form of the mu opioid antagonist axelopran sulfate in an immediate release form and an opioid analgesic agent which may be in an extended release, sustained release, modified release, or controlled release form and methods of preparing such a combination dosage form.